For a full list of side effects for these medications, visit the manufacturers website or look at the packaging insert
However, in April 2026, the PIL for Tirzepatide as Mounjaro was updated to state Tirzepatide passes into breastmilk in very low amounts and is not expected to be absorbed by a breastfed newborn/infant
Preserving lean mass including skeletal muscle Because GLP1based therapies are associated with ~30% of total weight loss coming from lean body mass 1 loss as weight falls, using a Diabetes Specific Nutritional Formula like Glucerna can help supply high-quality protein and micronutrients to support muscle maintenance (coupled with resistance exercise)
For most GLP-1 receptor agonists, consistent timing is important, but relation to meals is not critical
Common Medications Semaglutide (Wegovy and Ozempic for SQ injections, Rybelsus for PO) Liraglutide (Saxenda and Victoza for SQ injections) Tirzepatide (Mounjaro) Mechanism of Action GLP-1 is an incretin hormone produced in the small intestine, and it binds the GLP-1 receptor, thus enhancing the effects of endogenous GLP-1
That's something that should be reconsidered